Kyodo News on MSN32m
U.S. regulator OKs Eisai-Biogen Alzheimer's drug's continuous dosing
Japanese pharmaceutical company Eisai Co. and U.S. firm Biogen Inc. said Monday that a jointly developed Alzheimer's drug has been approved for continuous use for people with early stages of the ...
Hosted on MSN56mOpinion
Opinion: Immune System And Ageing — Why We Get More Vulnerable As We Age
By Dr Parinita Kaur As we age, our immune system undergoes significant changes that can affect its ability to protect the ...